Prenatal exposure to misoprostol and vascular disruption defects: a case-control study.
Prenatal exposure to misoprostol has been associated with Moebius and limb defects. Vascular disruption has been proposed as the mechanism for these teratogenic effects. The present study is a multicenter, case-control study that was designed to compare the frequency of prenatal misoprostol use between mothers of Brazilian children diagnosed with vascular disruption defects and matched control mothers of children diagnosed with other types of defects. A total of 93 cases and 279 controls were recruited in eight participating centers. Prenatal exposure was identified in 32 infants diagnosed with vascular disruption defects (34.4%) compared with only 12 (4.3%) in the control group (P<0.0000001). Our data suggest that prenatal exposure to misoprostol is associated to the occurrence of vascular disruption defects in the newborns.
Vargas
F R
FR
Hospital Universitário Gaffrée-Guinle, Universidade do Rio de Janeiro, Brazil. vargas@centroin.com.br
Schuler-Faccini
L
L
Brunoni
D
D
Kim
C
C
Meloni
V F
VF
Sugayama
S M
SM
Albano
L
L
Llerena
J C
JC
Almeida
J C
JC
Duarte
A
A
Cavalcanti
D P
DP
Goloni-Bertollo
E
E
Conte
A
A
Koren
G
G
Addis
A
A
D000014:Abnormalities, Drug-Induced / Q000503:physiopathology*; D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000284:Administration, Oral; D000328:Adult; D016022:Case-Control Studies; D005260:Female; D005333:Fetus / Q000098:blood supply* / Q000187:drug effects*; D006801:Humans; D017880:Limb Deformities, Congenital / Q000139:chemically induced / Q000503:physiopathology; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects*; D020331:Mobius Syndrome / Q000139:chemically induced / Q000503:physiopathology; D016017:Odds Ratio; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol